Search Results - "URETSKY, Barry F"

Refine Results
  1. 1

    Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes by Hakeem, Abdul, Uretsky, Barry F

    Published in Circulation (New York, N.Y.) (29-01-2019)
    “…The value of fractional flow reserve (FFR) in determining the appropriateness of percutaneous coronary intervention (PCI) has been well established and…”
    Get full text
    Journal Article
  2. 2

    Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes by Agarwal, Shiv K., MD, Kasula, Srikanth, MD, Hacioglu, Yalcin, MD, Ahmed, Zubair, MD, Uretsky, Barry F., MD, Hakeem, Abdul, MD

    Published in JACC. Cardiovascular interventions (23-05-2016)
    “…Abstract Objectives This study sought to evaluate the impact of fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) on subsequent…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The myocardium supplied by a chronic total occlusion is a persistently ischemic zone by Sachdeva, Rajesh, Agrawal, Mayank, Flynn, Shawn E., Werner, Gerald S., Uretsky, Barry F.

    “…Well‐developed collaterals to a myocardial segment supplied by a chronic total occlusion (CTO) and/or left ventricular dysfunction in the CTO regions in…”
    Get full text
    Journal Article
  6. 6

    STAR procedure becomes SAFER: First-in-man case series of a new antegrade dissection re-entry technique by Carlino, Mauro, Uretsky, Barry F, Azzalini, Lorenzo, Nascimbene, Angelo, Brilakis, Emmanouil S, Colombo, Antonio, Nakamura, Sunao, Godino, Cosmo, Avran, Alexandre, Rinfret, Stéphane, Faurie, Benjamin

    “…Antegrade dissection and re-entry (ADR) is an integral part of the hybrid algorithm, which has allowed for improved outcomes in chronic total occlusion (CTO)…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention by Pothineni, Naga V., MD, Shah, Nishi N., MD, Rochlani, Yogita, MD, Nairooz, Ramez, MD, Raina, Sameer, MD, Leesar, Massoud A., MD, Uretsky, Barry F., MD, Hakeem, Abdul, MD

    “…[...]this is an inpatient sample and outpatient FFR procedures are likely to have been missed particularly "deferred cases" not undergoing PCI. [...]all…”
    Get full text
    Journal Article
  10. 10

    Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry) by Nairooz, Ramez, Parzynski, Craig S., Curtis, Jeptha P., Mohsen, Amr, McNulty, Edward, Uretsky, Barry F., Hakeem, Abdul

    Published in The American journal of cardiology (01-09-2020)
    “…Coronary artery perforation (CP) is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). Given the marked increase…”
    Get full text
    Journal Article
  11. 11

    Pseudoaneurysm of the Mitral-Aortic Intervalvular Fibrosa (MAIVF): A Comprehensive Review by Sudhakar, Selvin, MD, Sewani, Asif, MD, Agrawal, Mayank, MD, Uretsky, Barry F., MD

    “…Pseudoaneurysm in the region of the fibrous body between the mitral and aortic valve, the mitral-aortic intervalvular fibrosa (MAIVF), is a rare complication…”
    Get full text
    Journal Article
  12. 12

    Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention by Uretsky, Barry F, Agarwal, Shiv K, Vallurupalli, Srikanth, Al-Hawwas, Malek, Hasan, Rimsha, Miller, Kristin, Hakeem, Abdul

    Published in Journal of the American Heart Association (04-02-2020)
    “…Background Long-term outcomes after percutaneous coronary intervention (PCI) relate in part to residual ischemia in the treated vessel, as reflected by…”
    Get full text
    Journal Article
  13. 13

    Systematic review of the evaluation and management of coronary pseudoaneurysm after stent implantation by Hassan, Atif, Uretsky, Barry F., Vargas Estrada, Andres M., Hassan, Romesa, Al‐Hawwas, Malek, Agarwal, Shiv Kumar

    “…Pseudoaneurysm (PSA) formation is a rare but well‐known complication of coronary stenting. It develops after a procedural perforation disrupts the integrity of…”
    Get full text
    Journal Article
  14. 14

    The Risk of Adverse Cardiac and Bleeding Events Following Noncardiac Surgery Relative to Antiplatelet Therapy in Patients With Prior Percutaneous Coronary Intervention by Singla, Sandeep, MD, Sachdeva, Rajesh, MD, Uretsky, Barry F., MD

    “…Noncardiac surgery (NCS) may be required within the first year after percutaneous coronary intervention (PCI) in approximately 4% of patients and is the second…”
    Get full text
    Journal Article
  15. 15

    Outcomes After Carotid Artery Stenting and Endarterectomy in the Medicare Population by FEN WEI WANG, ESTERBROOKS, Dennis, KUO, Yong-Fang, MOOSS, Aryan, MOHIUDDIN, Syed M, URETSKY, Barry F

    Published in Stroke (1970) (01-07-2011)
    “…Carotid artery stenting (CAS) is an alternative to carotid endarterectomy (CEA) for stroke prevention. The value of this therapy relative to CEA remains…”
    Get full text
    Journal Article
  16. 16

    Clinical and Angiographic Predictors of Persistently Ischemic Fractional Flow Reserve after Percutaneous Revascularization by Agarwal, Shiv Kumar, MD, Kasula, Srikanth, MD, Almomani, Ahmed, MD, Hacioglu, Yalcin, MD, Ahmed, Zubair, MD, Uretsky, Barry F, MD, Hakeem, Abdul, MD

    Published in The American heart journal (01-02-2017)
    “…Aims Despite optimal angiographic results after PCI, some lesions may continue to produce ischemia under maximal hyperemia. We evaluated the factors associated…”
    Get full text
    Journal Article
  17. 17

    Reversal of ischemia of donor artery myocardium after recanalization of a chronic total occlusion by Sachdeva, Rajesh, Agrawal, Mayank, Flynn, Shawn E., Werner, Gerald S., Uretsky, Barry F.

    “…Background Case reports have shown that an intermediate stenosis in the donor artery collateralizing the myocardium of a chronic total occlusion (CTO) can…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic Heart failure by PACKER, M, POOLE-WILSON, P. A, ARMSTRONG, P. W, CLELAND, J. G. F, HOROWITZ, J. D, MASSIE, B. M, RYDEN, L, THYGESEN, K, URETSKY, B. F

    Published in Circulation (New York, N.Y.) (07-12-1999)
    “…Background —Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by physicians in doses lower than the large doses that have been shown to…”
    Get full text
    Journal Article